| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| McCann UD, Ricaurte GA |
Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine... |
J Clin Psychopharmac... |
1991 |
| McCann UD, Ricaurte GA |
Major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA) do not m... |
Brain Res |
1991 |
| McCann UD, Ricaurte GA |
MDMA ('ecstasy') and panic disorder: induction by a single dose |
Biol Psychiatry |
1992 |
| Ricaurte GA, McCann UD |
Neurotoxic amphetamine analogues: effects in monkeys and implications ... |
Ann N Y Acad Sci |
1992 |
| Allen RP, McCann UD, Rica... |
Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, '... |
Sleep |
1993 |
| McCann UD, Ricaurte GA |
Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetam... |
J Clin Psychopharmac... |
1993 |
| McCann UD, Ricaurte GA |
Strategies for detecting subclinical monoamine depletions in humans |
NIDA Res Monogr |
1993 |
| McCann UD, Ridenour A, Sh... |
Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (... |
Neuropsychopharmacol... |
1994 |
| Steele TD, McCann UD, Ric... |
3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and ... |
Addiction |
1994 |
| McCann UD, Ricaurte GA |
On the neurotoxicity of MDMA and related amphetamine derivatives [lett... |
J Clin Psychopharmac... |
1995 |
| McCann UD, Slate SO, Rica... |
Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'Ecsta... |
Drug Safety |
1996 |
| Bolla KI, McCann UD, Rica... |
Memory impairment in abstinent MDMA ('Ecstasy') users |
Neurology |
1998 |
| McCann UD, Szabo Z, Schef... |
Positron emission tomographic evidence of toxic effect of MDMA ('Ecsta... |
Lancet |
1998 |
| McCann UD, Szabo Z, Schef... |
Toxic effect of MDMA on brain serotonin neurons |
Lancet |
1999 |
| McCann UD, Szabao Z, Sche... |
Positron emission tomography findings in heavy users of MDMA |
Lancet |
1999 |
| Hatzidimitriou G, McCann ... |
Altered serotonin innervation patterns in the forebrain of monkeys tre... |
J Neurosci |
1999 |
| McCann UD, Mertl M, Eligu... |
Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA... |
Psychopharmacology (... |
1999 |
| McCann UD, Eligulashvili ... |
Altered neuroendocrine and behavioral responses to m-chlorophenylpiper... |
Psychopharmacology (... |
1999 |
| McCann UD, Eligulashvili ... |
(+/-)3,4-Methylenedioxymethamphetamine (`Ecstasy')-Induced Serotonin N... |
Neuropsychobiology |
2000 |
| Ricaurte GA, Yuan J, McCa... |
(+/-)3,4-Methylenedioxymethamphetamine (`Ecstasy')-Induced Serotonin N... |
Neuropsychobiology |
2000 |
| Ricaurte GA, McCann UD, S... |
Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-m... |
Toxicol Lett |
2000 |
| McCann UD, Ricaurte GA |
Caveat Emptor: Editors Beware |
Neuropsychopharmacol... |
2001 |
| McCann UD, Ricaurte GA, M... |
'Ecstasy' and serotonin neurotoxicity: New findings raise more questio... |
Archives of General ... |
2001 |
| Ricaurte GA, McCann UD |
Assessing long-term effects of MDMA (Ecstasy) |
Lancet |
2001 |
| Winsauer PJ, McCann UD, Y... |
Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition i... |
Psychopharmacology (... |
2002 |
| Hatzidimitriou G, Tsai EH... |
Altered prolactin response to M-chlorophenylpiperazine in monkeys prev... |
Synapse |
2002 |
| Yuan J, Cord BJ, McCann U... |
Effect of depleting vesicular and cytoplasmic dopamine on methylenedio... |
J Neurochem |
2002 |
| Szabo Z, McCann UD, Wilso... |
Comparison of (+)-(11)C-McN5652 and (11)C-DASB as Serotonin Transporte... |
J Nucl Med |
2002 |
| Bobes J, Saiz PA, Gonzale... |
Use of MDMA and Other Illicit Drugs by Young Adult Males in Northern S... |
Eur Addict Res |
2002 |
| Ricaurte GA, Yuan J, Hatz... |
Severe Dopaminergic Neurotoxicity in Primates After a Common Recreatio... |
Science |
2002 |
| Yuan J, Cord BJ, McCann U... |
Effect of glucoprivation on serotonin neurotoxicity induced by substit... |
J Pharmacol Exp Ther |
2002 |
| Boot BP, Mechan AO, McCan... |
MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentratio... |
Eur J Pharmacol |
2002 |
| Ricaurte GA, Yuan J, Hatz... |
Retraction |
Science |
2003 |
| Mechan A, Yuan J, Hatzidi... |
Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in S... |
Neuropsychopharmacol... |
2005 |
| McCann UD, Szabo Z, Secki... |
Quantitative PET Studies of the Serotonin Transporter in MDMA Users an... |
Neuropsychopharmacol... |
2005 |
| Irvine RJ, Keane M, Felga... |
Plasma drug concentrations and physiological measures in 'dance party'... |
Neuropsychopharmacol... |
2006 |
| Griffiths RR, Richards WA... |
Psilocybin can occasion mystical-type experiences having substantial a... |
Psychopharmacology (... |
2006 |
| Griffiths RR, Richards WA... |
Mystical-type experiences occasioned by psilocybin mediate the attribu... |
J Psychopharm |
2008 |
| McCann UD, Szabo Z, Vrane... |
Positron emission tomographic studies of brain dopamine and serotonin ... |
Psychopharmacology (... |
2008 |
| Mueller MA, Yuan J, Neudo... |
Further Studies on the Role of Metabolites in MDMA-induced Serotonergi... |
Drug Metab Dispos |
2009 |
| Mueller M, Goodwin AK, At... |
Metabolism and Disposition of 3,4-Methylenedioxymethamphetamine (MDMA,... |
J Pharmacol Exp Ther |
2011 |
| Griffiths RR, Johnson MW,... |
Psilocybin occasioned mystical-type experiences: immediate and persist... |
Psychopharmacology (... |
2011 |
